---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042727"
form_type: "8-K12G3"
ticker: null
cik: "0002042814"
company_name: "Nascent Pharma Holdings, Inc."
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:51:06.700411+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Nascent Pharma Holdings succeeds Can B Corp. as public holding company via stock-for-stock merger

## Summary
- Each share of Can B common and preferred converted 1:1 into equivalent Nascent share; no stockholder vote required.
- Outstanding shares: 71,239,311 common, 5 Series A, 1,100 Series C, 4,000 Series D preferred; all classes unchanged.
- Same board and officers continue: Marco Alfonsi (CEO), Stanley L. Teeple (CFO, Secretary).
- Nascent adopted a Code of Business Conduct and Ethics and an Incentive Stock Option Plan.
- New trading symbol not yet assigned; FINRA processing pending.

## SEC filing metadata
- accession: 0001493152-24-042727
- form_type: 8-K12G3
- cik: 0002042814
- company_name: Nascent Pharma Holdings, Inc.
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 5.02, 5.05, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/form8-k12g3.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042727
- JSON: https://secwatch.observer/filing/0001493152-24-042727.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042727.txt

## Key facts
- Governance Changes
  Nascent Pharma Holdings, Inc.: Adopted new Articles of Incorporation substantially identical to prior Can B articles except for name change (effective 2024-09-13).
  - Change: charter amendment
  - Effective: 2024-09-13
  source text: The Nascent Articles of Incorporation were filed with the Florida Secretary of State on September 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm
- Governance Changes
  Nascent Pharma Holdings, Inc.: Adopted new Bylaws substantially identical to prior Can B bylaws except for name change.
  - Change: bylaw amendment
  source text: adopted the Bylaws of Nascent (the “ Nascent Bylaws ”) that each contains provisions substantially identical to those of Can B immediately prior to the consummation of the Nascent Merger, except for the change of the name of the corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm
- Governance Changes
  Nascent Pharma Holdings, Inc.: Adopted a Code of Business Conduct and Ethics (effective 2024-10-24).
  - Change: code of ethics
  - Effective: 2024-10-24
  source text: On October 24, 2024, Nascent adopted a Code of Business Conduct and Ethics (the “ Code ”) that was approved by the Board of Directors on October 25, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/2042814/000149315224042727/0001493152-24-042727-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.